SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001140361-15-006169
Filing Date
2015-02-13
Accepted
2015-02-13 09:45:46
Documents
1
Group Members
SCHRODER INVESTMENT MANAGEMENT HONG KONG LTDSCHRODER INVESTMENT MANAGEMENT LTDSCHRODER INVESTMENT MANAGEMENT NORTH AMERICA LTDSCHRODER INVESTMENT MANAGEMENT SINGAPORE LTD

Document Format Files

Seq Description Document Type Size
1 SCHRODER INVESTMENT MANAGEMENT NORTH AMERICA INC. SC 13GA 12-31-2014 (WUXI PHARM formsc13ga.htm SC 13G/A 121062
  Complete submission text file 0001140361-15-006169.txt   122864
Mailing Address 875 THIRD AVENUE, 22ND FLOOR NEW YORK NY 10022
Business Address 875 THIRD AVENUE, 22ND FLOOR NEW YORK NY 10022 212-641-3800
SCHRODER INVESTMENT MANAGEMENT NORTH AMERICA INC/ DE (Filed by) CIK: 0001105005 (see all company filings)

IRS No.: 134064414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131
Business Address 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131 86-21-5046-1111
WuXi PharmaTech (Cayman) Inc. (Subject) CIK: 0001403132 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-83350 | Film No.: 15609452
SIC: 2834 Pharmaceutical Preparations